Evidence map›Paper›PMID 36317592›Full record

ArticlePersonalized medicine2022

Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experiment.

Cheng Chen, Melissa H Roberts, Dennis W Raisch, Todd A Thompson, Amy Bachyrycz, Matthew E Borrego

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cheng ChenDepartment of Clinical Pharmacy, Center for Translational & Policy Research on Precision Medicine (TRANSPERS), University of California, San Francisco, CA 94143, USA.ORCID 0000-0001-5240-8284
Melissa H RobertsCollege of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, USA.ORCID 0000-0002-1314-4906
Dennis W RaischCollege of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, USA.
Todd A ThompsonCollege of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, USA.
Amy BachyryczCollege of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, USA.
Matthew E BorregoCollege of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, USA.

Funding

BUILDING THE EVIDENCE BASE FOR APPROPRIATE AND EFFICIENT IMPLEMENTATION OF EMERGING GENOMIC TESTS FOR DISEASE MANAGEMENT AND SCREENINGR01HG011792 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PHILLIPS, KATHRYN A · 2021 to 2025
$4.6M
NHGRI NIH HHS R01 HG011792
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug-Related Side Effects and Adverse ReactionsPharmacogenomic TestingAdultConfidentialityHumansPharmacogeneticsPolypharmacyDCEdiscrete choice experimentpatient preferencesPGxpharmacogenomic testpolypharmacy

Identifiers

PMID36317592
PMCPMC10859042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.